Publications Implementing an electronic end-of-life chemotherapy utilization measure March 19, 2020 Kraut J, Mooney K, Sweetenham JW, Page RD, Adelson K, Agarwala V, Fessele KL, Hamrick HJ, Kaganman I, Martineau J, Abernethy AP, and Meropol NJ. Journal of Oncology Practice. . http://ascopubs.org/doi/abs/10.1200/JOP.18.00408 Authors:Kraut J, Mooney K, Sweetenham JW, Page RD, Adelson K, Agarwala V, Fessele KL, Hamrick HJ, Kaganman I, Martineau J, Abernethy AP, and Meropol NJ Sources:Journal of Oncology Practice Read the research SharePosted inTreatment and Testing patterns More publicationsNovember 2026Treatment patterns and outcomes post-CAR T failure in LBCL: the "what comes next" questionNovember 2026Real-world comparison of biologic features, treatment patterns, and clinical outcomes between younger (≤55 years) and older (>55 years) patients with CLL receiving frontline targeted therapyNovember 2026When MRD matters: clinical interpretation and treatment decision-making after measurable residual disease testing in multiple myeloma
November 2026Treatment patterns and outcomes post-CAR T failure in LBCL: the "what comes next" question
November 2026Real-world comparison of biologic features, treatment patterns, and clinical outcomes between younger (≤55 years) and older (>55 years) patients with CLL receiving frontline targeted therapy
November 2026When MRD matters: clinical interpretation and treatment decision-making after measurable residual disease testing in multiple myeloma